212 related articles for article (PubMed ID: 25843554)
21. New discoveries in the genetics and genomics of systemic juvenile idiopathic arthritis.
Correia Marques M; Ombrello MJ; Schulert GS
Expert Rev Clin Immunol; 2024 May; ():1-12. PubMed ID: 38641907
[TBL] [Abstract][Full Text] [Related]
22. Pediatric systemic juvenile idiopathic arthritis-related lung disease: Description of clinical cohort and review of management.
Swanson C; Khan EK; Cooper A; Ibarra M; Tam-Williams J
Pediatr Pulmonol; 2024 Mar; 59(3):724-733. PubMed ID: 38155594
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Refractory macrophage activation syndrome requiring high-dose anakinra, emapalumab, and etoposide therapy in early-onset systemic juvenile idiopathic arthritis associated with adenoviremia.
Slaney ED; Modica R; Woolnough L; Kafisheh D; Bell-Brunson DH; Elder M
Front Pediatr; 2023; 11():1336554. PubMed ID: 38322244
[TBL] [Abstract][Full Text] [Related]
24. Short-Term Outcomes and Predictors of Effectiveness of Tocilizumab in Systemic Juvenile Idiopathic Arthritis: A Prospective Cohort Study.
Nada DW; Moghazy A; Allam AE; Alunno A; Ibrahim AM
Front Med (Lausanne); 2021; 8():665028. PubMed ID: 34041254
[No Abstract] [Full Text] [Related]
25. Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients with Congenital Heart Disease.
Pontes Aires B; Wobma H; Samad A; Chandler MT; Chang MH; Dedeoglu F; Fishman MP; Klouda T; Levin J; Halyabar O; Saleeb SF; Tworetzky W; Son MBF; Newburger JW; Casey A; Henderson LA
J Rheumatol; 2024 Jun; ():. PubMed ID: 38825355
[TBL] [Abstract][Full Text] [Related]
26. A MASsive attack: a pediatric case of macrophage activation syndrome complicated by DIC as an onset of systemic juvenile idiopathic arthritis successfully treated with anakinra and review of the literature.
Maeser A; Biernacka-Zielinska M; Smolewska E
Rheumatol Int; 2024 Mar; ():. PubMed ID: 38502236
[TBL] [Abstract][Full Text] [Related]
27. The Conundrum of Lung Disease and Drug Hypersensitivity-like Reactions in Systemic Juvenile Idiopathic Arthritis.
Binstadt BA; Nigrovic PA
Arthritis Rheumatol; 2022 Jul; 74(7):1122-1131. PubMed ID: 35413159
[TBL] [Abstract][Full Text] [Related]
28. The 4
Canna SW; De Benedetti F
Pediatr Rheumatol Online J; 2024 Jan; 21(Suppl 1):79. PubMed ID: 38183056
[TBL] [Abstract][Full Text] [Related]
29. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or -6 therapy.
Ulu K; Aliyev E; Kılıç Könte E; Tanatar A; Türkmen Ş; Doğantan Ş; Kızıldağ Z; Kasap Demir B; Gezgin Yıldırım D; Otar Yener G; Öztürk K; Baba Ö; Açarı C; Kılbaş G; Taşkın SN; Haşlak F; Çağlayan Ş; Bağlan E; Dundar HA; Başaran Ö; Barut K; Karadağ ŞG; Coşkuner T; Sönmez HE; Yüksel S; Kalyoncu M; Bakkaloğlu SA; Ünsal E; Paç Kısaarslan A; Bilginer Y; Aktay Ayaz N; Kasapçopur Ö; Özen S; Sözeri B
Rheumatology (Oxford); 2024 Mar; ():. PubMed ID: 38441301
[TBL] [Abstract][Full Text] [Related]
30. Predictors of disease course in systemic juvenile idiopathic arthritis.
Kaplan MM; Tekin ZE; Çelikel E; Güngörer V; Karagöl C; Öner N; Polat MC; Öztürk D; Özçelik E; Ekici MI; Acar BÇ
Mod Rheumatol; 2024 Apr; ():. PubMed ID: 38590038
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Management of the Systemic Juvenile Idiopathic Arthritis Patient with Emerging Lung Disease.
Towe C; Grom AA; Schulert GS
Paediatr Drugs; 2023 Nov; 25(6):649-658. PubMed ID: 37787872
[TBL] [Abstract][Full Text] [Related]
32. The clinical and experimental treatment of Juvenile Idiopathic Arthritis.
Nijhuis L; Swart JF; Prakken BJ; van Loosdregt J; Vastert SJ
Clin Exp Immunol; 2023 Oct; 213(3):276-287. PubMed ID: 37074076
[TBL] [Abstract][Full Text] [Related]
33. Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005-2021).
Foley CM; McKenna D; Gallagher K; McLellan K; Alkhdher H; Lacassagne S; Moraitis E; Papadopoulou C; Pilkington C; Al Obaidi M; Eleftheriou D; Brogan P
Front Pediatr; 2023; 11():1218312. PubMed ID: 37780048
[TBL] [Abstract][Full Text] [Related]
34. Population-level single-cell genomics reveals conserved gene programs in systemic juvenile idiopathic arthritis.
Verweyen EL; Thakkar K; Dhakal S; Baker E; Chetal K; Schnell D; Canna S; Grom AA; Salomonis N; Schulert GS
J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37733441
[TBL] [Abstract][Full Text] [Related]
35. Systemic arthritis in children: a review of clinical presentation and treatment.
Gurion R; Lehman TJ; Moorthy LN
Int J Inflam; 2012; 2012():271569. PubMed ID: 22235382
[TBL] [Abstract][Full Text] [Related]
36. Treatment of systemic-onset juvenile arthritis with canakinumab.
Peitz J; Horneff G
Open Access Rheumatol; 2015; 7():23-31. PubMed ID: 27790042
[TBL] [Abstract][Full Text] [Related]
37. Extracellular vesicles in systemic juvenile idiopathic arthritis.
Maller J; Morgan T; Morita M; McCarthy F; Jung Y; Svensson KJ; Elias JE; Macaubas C; Mellins E
J Leukoc Biol; 2023 Oct; 114(5):387-403. PubMed ID: 37201912
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
Avau A; Matthys P
Pharmaceuticals (Basel); 2015 Nov; 8(4):793-815. PubMed ID: 26610523
[TBL] [Abstract][Full Text] [Related]
39. RNAseq-based transcriptomics of treatment-naïve multi-inflammatory syndrome in children (MIS-C) demonstrates predominant activation of matrisome, innate and humoral immune pathways.
Patnaik S; Mruthyunjaya P; Murmu KC; Mahapatra S; Patro ARK; Misra R; Pati S; Prasad P; Ahmed S
Rheumatol Int; 2023 Oct; ():. PubMed ID: 37823896
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
